Retraction: "The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombination." [Molecular and Cellular Biology, 33, 9, (2013), (1768-1781)] doi: 10.1128/MCB.00987-12;The bcl11a transcription factor directly activates RAG gene expression and V(D)J recombination

Molecular and Cellular Biology

Volumn 33, Issue 9, 2013, Pages 1768-1781

  Lee, Baeck Seung ^a,b   Dekker, Joseph D ^a   Lee, Bum Kyu ^a   Iyer, Vishwanath R ^a   Sleckman, Barry P ^b   Shaffer III, Arthur L ^c   Ippolito, Gregory C ^a   Tuckera, Philip W ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAG1 PROTEIN; RAG2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BCL11A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FATE; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC RECOMBINATION; NONHUMAN; PRIORITY JOURNAL; VARIABLE DIVERSITY JOINING SEGMENT RECOMBINATION;

EID: 84876435579     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00358-17     Document Type: Erratum

References (65)

1. van Gent DC, McBlane JF, Ramsden DA, Sadofsky MJ, Hesse JE, Gellert M. 1995. Initiation of V(D)J recombination in a cell-free system. Cell 81:925-934.
2. Oettinger MA, Schatz DG, Gorka C, Baltimore D. 1990. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248:1517-1523.
3. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
4. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-867.
5. McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, Oettinger MA. 1995. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83: 387-395.
6. Schatz DG. 2004. V(D)J recombination. Immunol. Rev. 200:5-11.
7. Amin RH, Schlissel MS. 2008. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9:613-622.
8. Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH, DePinho RA, Rickert RC. 2008. Distinct functions for the transcription factor FoxO1 at various stages of B cell differentiation. Nat. Immunol. 9:1388-1398.
9. Fuller K, Storb U. 1997. Identification and characterization of the murine Rag1 promoter. Mol. Immunol. 34:939-954.
10. Hsu LY, Lauring J, Liang HE, Greenbaum S, Cado D, Zhuang Y, Schlissel MS. 2003. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19:105-117.
11. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, Tucker PW, Rao A. 2006. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 7:819-826.
12. Kishi H, Jin ZX, Wei XC, Nagata T, Matsuda T, Saito S, Muraguchi A. 2002. Cooperative binding of c-Myb and Pax-5 activates the RAG-2 promoter in immature B cells. Blood 99:576-583.
13. Lauring J, Schlissel MS. 1999. Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines. Mol. Cell. Biol. 19:2601-2612.
14. Ochiai K, Maienschein-Cline M, Mandal M, Triggs JR, Bertolino E, Sciammas R, Dinner AR, Clark MR, Singh H. 2012. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat. Immunol. 13:300-307.
15. Verkoczy L, Ait-Azzouzene D, Skog P, Martensson A, Lang J, Duong B, Nemazee D. 2005. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22:519-531.
16. Wei XC, Dohkan J, Kishi H, Wu CX, Kondo S, Muraguchi A. 2005. Characterization of the proximal enhancer element and transcriptional regulatory factors for murine recombination activating gene-2. Eur. J. Immunol. 35:612-621.
17. Wei XC, Kishi H, Jin ZX, Zhao WP, Kondo S, Matsuda T, Saito S, Muraguchi A. 2002. Characterization of chromatin structure and enhancer elements for murine recombination activating gene-2. J. Immunol. 169:873-881.
18. Borghesi L, Aites J, Nelson S, Lefterov P, James P, Gerstein R. 2005. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202:1669-1677.
19. Reynaud D, Demarco IA, Reddy KL, Schjerven H, Bertolino E, Chen Z, Smale ST, Winandy S, Singh H. 2008. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9:927-936.
20. Fell HP, Smith RG, Tucker PW. 1986. Molecular analysis of the t(2;14) translocation of childhood chronic lymphocytic leukemia. Science 232: 491-494.
21. Mitelman F, Johansson B, Mertens F. 2004. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat. Genet. 36:331-334.
22. Richardson AL, Humphries CG, Tucker PW. 1992. Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia. Oncogene 7:961-970.
23. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJ. 2001. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98:3413-3420.
24. Avram D, Fields A, Pretty On Top K, Nevrivy DJ, Ishmael JE, Leid M. 2000. Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J. Biol. Chem. 275:10315-10322.
25. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG. 2003. Bcl11a is essential for normal lymphoid development. Nat. Immunol. 4:525-532.
26. Matthews JM, Kowalski K, Liew CK, Sharpe BK, Fox AH, Crossley M, MacKay JP. 2000. A class of zinc fingers involved in protein-protein interactions biophysical characterization of CCHC fingers from fog and U-shaped. Eur. J. Biochem. 267:1030-1038.
27. Pulford K, Banham AH, Lyne L, Jones M, Ippolito GC, Liu H, Tucker PW, Roncador G, Lucas E, Ashe S, Stockwin L, Walewska R, Karran L, Gascoyne RD, Mason DY, Dyer MJ. 2006. The BCL11A-XL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia 20:1439-1441.
28. Raney BJ, Cline MS, Rosenbloom KR, Dreszer TR, Learned K, Barber GP, Meyer LR, Sloan CA, Malladi VS, Roskin KM, Suh BB, Hinrichs AS, Clawson H, Zweig AS, Kirkup V, Fujita PA, Rhead B, Smith KE, Pohl A, Kuhn RM, Karolchik D, Haussler D, Kent WJ. 2011. ENCODE whole-genome data in the UCSC genome browser (2011 update). Nucleic Acids Res. 39:D871-D875. doi:10.1093/nar/gkq1017.
29. Sankaran VG, Xu J, Ragoczy T, Ippolito CG, Walkley CR, Maika SD, Fujiwara Y, Ito M, Groudine M, Bender MA, Tucker PW, Orkin SH. 2009. Developmental and species-divergent globin switching are driven by BCL11A. Nature 460:1093-1097.
30. Liu H, Ippolito GC, Wall JK, Niu T, Probst L, Lee BS, Pulford K, Banham AH, Stockwin L, Shaffer AL, Staudt LM, Das C, Dyer MJ, Tucker PW. 2006. Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Mol. Cancer 5:18. doi:10 .1186/1476-4598-5-18.
31. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA, Copeland NG. 2002. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32:166-174.
32. Yu Y, Wang J, Khaled W, Burke S, Li P, Chen X, Yang W, Jenkins NA, Copeland NG, Zhang S, Liu P. 2012. Bcl11a is essential for lymphoid development and negatively regulates p53. J. Exp. Med. 209:2467-2483.
33. Sandelin A, Bailey P, Bruce S, Engstrom PG, Klos JM, Wasserman WW, Ericson J, Lenhard B. 2004. Arrays of ultraconserved non-coding regions span the loci of key developmental genes in vertebrate genomes. BMC Genomics 5:99. doi:10.1186/1471-2164-5-99.
34. Xu J, Cong P, Sankaran VG, Shao Z, Esrick EB, Chong BG, Ippolito GC, Fujiwara Y, Ebert BL, Tucker PW, Orkin SH. 2011. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334:993-996.
35. Xu J, Sankaran VG, Ni M, Menne TF, Puram RV, Kim W, Orkin SH. 2010. Transcriptional silencing of gamma-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 24:783-798.
36. Ma S, Pathak S, Trinh L, Lu R. 2008. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to downregulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 111:1396-1403.
37. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212.
38. Ngo V, Davis R, Lamy L, Yu X, Zhao H, Lenz G, Lam L, Dave S, Yang L, Powell J. 2006. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441:106-110.
39. Bredemeyer AL, Sharma GG, Huang CY, Helmink BA, Walker LM, Khor KC, Nuskey B, Sullivan KE, Pandita TK, Bassing CH, Sleckman BP. 2006. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442:466-470.
40. Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA, Copeland NG. 2000. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell protooncogene product. Mol. Cell. Biol. 20:3178-3186.
41. Ramsden D. 1994. Kappa light chain rearrangement in mouse fetal liver. J. Immunol. 153:1150-1160.
42. Fu WJ, Hu J, Spencer T, Carroll R, Wu G. 2006. Statistical models in assessing fold change of gene expression in real-time RT-PCR experiments. Comput. Biol. Chem. 30:21-26.
43. Yuan JS, Reed A, Chen F, Stewart CN. 2006. Statistical analysis of real-time PCR data. BMC Bioinformatics 7:85. doi:10.1186/1471-2105-7-85.
44. Reyes JC, Muchardt C, Yaniv M. 1997. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol. 137:263-274.
45. Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH. 1997. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90:109-119.
46. Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, Avram D. 2005. BCL11B functionally associates with theNuRDcomplex in T lymphocytes to repress targeted promoter. Oncogene 24:6753-6764.
47. Muljo S, Schlissel M. 2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat. Immunol. 4:31-37.
48. Lin WC, Desiderio S. 1994. Cell cycle regulation of V(D)J recombinationactivating protein RAG-2. Proc. Natl. Acad. Sci. U. S. A. 91:2733-2737.
49. Lu R, Medina KL, Lancki DW, Singh H. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17:1703-1708.
50. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 101:6062-6067.
51. Chen Z, Xiao Y, Zhang J, Li J, Liu Y, Zhao Y, Ma C, Luo J, Qiu Y, Huang G, Korteweg C, Gu J. 2011. Transcription factors E2A, FOXO1 and FOXP1 regulate recombination activating gene expression in cancer cells. PLoS One 6:e20475. doi:10.1371/journal.pone.0020475.
52. Laszkiewicz A, Sniezewski L, Kasztura M, Bzdzion L, Cebrat M, Kisielow P. 2012. Bidirectional activity of the NWC promoter is responsible for RAG-2 transcription in non-lymphoid cells. PLoS One 7:e44807. doi:10.1371/journal.pone.0044807.
53. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J. 2003. Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res. 63:6488-6495.
54. Zheng H, Li M, Liu H, Ren W, Hu DS, Shi Y, Tang M, Cao Y. 2007. Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol. Int. 31:82-87.
55. Seita J, Sahoo D, Rossi DJ, Bhattacharya D, Serwold T, Inlay MA, Ehrlich LI, Fathman JW, Dill DL, Weissman IL. 2012. Gene Expression Commons: an open platform for absolute gene expression profiling. PLoS One 7:e40321. doi:10.1371/journal.pone.0040321.
56. Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, Hitomi J, Yamamoto T, Utsuyama M, Niwa O, Aizawa S, Kominami R. 2003. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat. Immunol. 4:533-539.
57. Inoue J, Kanefuji T, Okazuka K, Watanabe H, Mishima Y, Kominami R. 2006. Expression of TCR alpha beta partly rescues developmental arrest and apoptosis of alpha beta T cells in Bcl11b-/- mice. J. Immunol. 176: 5871-5879.
58. Bond HM, Mesuraca M, Caarbone E, Bonelli P, Agosti V, Amodio N, De Rosa G, Di Nicola M, Gianni AM, Moore MA, Hata A, Grieco M, Morrone G, Venuta S. 2004. Early hematopoietic zinc finger protein(EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood 103:2062-2070.
59. Fitzsimmons SP, Bernstein RM, Max EE, Skok JA, Shapiro MA. 2007. Dynamic changes in accessibility, nuclear positioning, recombination, and transcription at the Ig kappa locus. J. Immunol. 179:5264-5273.
60. Goldmit M, Ji Y, Skok J, Roldan E, Jung S, Cedar H, Bergman Y. 2005. Epigenetic ontogeny of the Igk locus during B cell development. Nat. Immunol. 6:198-203.
61. Perkins EJ, Kee BL, Ramsden DA. 2004. Histone 3 lysine 4 methylation during the pre-B to immature B-cell transition. Nucleic Acids Res. 32: 1942-1947.
62. Angelin-Duclos C, Calame K. 1998. Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment. Mol. Cell. Biol. 18:6253-6264.
63. Corcoran AE, Riddell A, Krooshoop D, Venkitaraman AR. 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391:904-907.
64. Corcoran AE, Smart FM, Cowling RJ, Crompton T, Owen MJ, Venkitaraman AR. 1996. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15:1924-1932.
65. Brown ST, Miranda GA, Galic Z, Hartman IZ, Lyon CJ, Aguilera RJ. 1997. Regulation of the RAG-1 promoter by the NF-Y transcription factor. J. Immunol. 158:5071-5074.